Laboratorios Farmaceuticos Rovi. SA

Laboratorios Farmaceuticos Rovi, SA is a leading Spanish pharmaceutical company that specializes in the research, development, and commercialization of innovative medicines and healthcare products. With a long-standing reputation for excellence in the industry, Rovi is dedicated to meeting the needs of patients and healthcare professionals. Its product portfolio includes a wide range of therapeutic areas, such as hematology, oncology, gastroenterology, and cardiology. Rovi's flagship product, Diclofenaco Rovi, is a nonsteroidal anti-inflammatory drug used to treat pain and inflammation. The company also produces biosimilars, including Enoxaparina Rovi, a low molecular weight heparin used to prevent blood clots. Rovi invests heavily in research and development to bring new and improved products to market. With a strong presence in over 80 countries worldwide, Rovi is committed to sustainability and social responsibility, reducing its environmental impact and supporting local communities. With a dedicated team of professionals and a commitment to excellence, Rovi is poised for continued growth and success in the global pharmaceutical industry.